The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.

Authors
Category Primary study
JournalHealth Technology Assessment
Year 2005
This article has no abstract
Epistemonikos ID: 494a77f61d3c3151946f7b0080c356191e9415ba
First added on: Apr 04, 2025